Project Details
Abstract
The project addresses a major gap in biomarkers for the stratification of triple negative breast cancer patients for immunotherapy. By integrating bioinformatics, experimental validation and proof-of-concept studies, we aim to uncover the biological mechanisms by which epigenetically silenced genes regulate cancer immunity. The outcomes will enable the development of predictive immune-related biomarkers to identify patients most likely to benefit from immunotherapy and/or strategies to improve clinical outcome, deriving benefit from precision medicine.
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
| Sponsor's Award Number | IGP8-2026_005 |
|---|---|
| Proposal ID | QBRI-CORE-000024 |
| Status | Active |
| Effective start/end date | 1/01/26 → 31/12/28 |
Primary Theme
- Precision Health
Primary Subtheme
- PH - Diagnosis Treatment
Secondary Theme
- None
Secondary Subtheme
- None
Keywords
- Triple negative breast cancer Immunotherapy Precision medicine
- None
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.